Product Wiki · Recalls · EU Safety Gate (RAPEX)

495 Instant adhesive - Quick drying - Specific glue — recall SR/02616/26

EU Safety Gate (RAPEX) · France · 2026-09-25 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/02616/26
Date of alert
2026-09-25
Country / jurisdiction
France
Risk level
Serious risk
Risk type
Chemical
Brand
LOOLIFL
Product category
Chemical products
Product type
Glue
🔴 Serious hazard — Reported risk: The product contains cyanoacrylates that can bond skin and eyes in seconds. The product however does not display the required warnings and hazard labels. Therefore users are not properly informed about the dangers incurred when the product comes into contact with the skin and eyes. The product does not comply with the Regulation on classification, labelling and packaging of substances and mixtures (CLP).
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Recall of the product from end users
Date of entry into force
15/07/2026
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10118551

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.